Stock listing

Aelis Farma Sa

Selected listing: AELIS · EURONEXT · EUR · FR

Aelis Farma Sa (Euronext:AELIS), Health Technology. Latest release Sep 24, 2026: Aelis Farma: Availability of the 2026 Half-Year Financial Report.

AELIS:EURONEXTEURFRUpdated October 2, 2026

Ticker: Euronext:AELIS
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Euronext
Currency: EUR

About Aelis Farma Sa

Aelis Farma SA is a public company listed on the French market under the ticker AELIS. Aelis Farma focuses on developing innovative therapies for central nervous system disorders.

Latest news from Aelis Farma Sa

Aelis Farma: Availability of the 2026 Half-Year Financial Report

September 24, 2026

Aelis Farma Reports 2026 Half-Year Financial Results and Presents Progress and Development Outlook

September 15, 2026

Aelis Farma Receives a Positive Recommendation From the Independent Data Monitoring Committee to Continue the Phase 2b Study of AEF0217 in People With Down Syndrome Without Modification

July 16, 2026

Aelis Farma: Availability of the Description of the Share Buyback Program

June 22, 2026

Results of Aelis Farma Combined General Meeting of June 3, 2026

June 4, 2026

All Aelis Farma Sa news →

Research Aelis Farma Sa

Aelis Farma Sa company profile

View the public company page for Aelis Farma Sa on 6ix.

Aelis Farma Sa news

Read company news and market updates connected to Aelis Farma Sa.

Aelis Farma Sa investor events

Find investor webinars, events, and replay context for Aelis Farma Sa.